Efficacy and safety of long-acting risperidone injection after switching from antipsychotics in Chinese patients

被引：0
|
作者：
Li, H. F. [1 ]
Gu, N. F. [1 ]
Zhou, M. [2 ]
Jia, F. J. [3 ]
Zhao, Z. H. [4 ]
Fan, J. X. [5 ]
Wang, G. [6 ]
Sun, X. L. [7 ]
Li, M. [8 ]
Zhang, J. B. [9 ]
机构：
[1] Shanghai Mental Hlth Ctr, Shanghai, Peoples R China
[2] Beijing Univ, Mental Hlth Inst, Beijing, Peoples R China
[3] Guangdong Mental Hlth Inst, Guangdong, Peoples R China
[4] GuangZhou Brain Hosp, Guangdong, Peoples R China
[5] Nanjing Brain Hosp, Dept Psychiat, Nanjing, Peoples R China
[6] Beijing Anding Hosp, Beijing, Peoples R China
[7] Sichuan Huaxi Hosp, Dept Psychiat, Chengdu, Peoples R China
[8] SuZhou Guangji Hosp, Suzhou, Peoples R China
[9] Zhongshan Univ, Affiliated Hosp 3, Guangdong, Peoples R China
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2007年 / 17卷
关键词：
D O I：
10.1016/S0924-977X(07)70606-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S405 / S406
页数：2
相关论文
共 50 条
  • [41] Long-acting risperidone:: Focus on safety
    Mueller, Hans-Juergen
    CLINICAL THERAPEUTICS, 2006, 28 (05) : 633 - 651
  • [42] A pharmacoeconomic outcomes analysis comparing risperidone long-acting injection and conventional depot antipsychotics
    Snaterse, M.
    Welch, R.
    VALUE IN HEALTH, 2007, 10 (06) : A298 - A298
  • [43] Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection
    Samalin, L.
    Charpeaud, T.
    Lorabi, O.
    Llorca, P. M.
    PATIENT PREFERENCE AND ADHERENCE, 2010, 4 : 325 - 334
  • [44] The influence of switching from oral risperidone to risperidone long-acting injection on the clinical symptoms and cognitive function in schizophrenia
    Suzuki, Hidenobu
    Gen, Keishi
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2012, 2 (01) : 23 - 29
  • [45] Patients' acceptance of the deltoid application of risperidone long-acting injection
    Heres, Stephan
    Frobose, Teresa
    Hamann, Johannes
    Leucht, Stefan
    Maino, Katja
    Reichhart, Tatjana
    Stiegler, Michaela
    Kissling, Werner
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 (12) : 897 - 901
  • [46] French psychotic patients treated with risperidone long-acting injectable: Improved efficacy and safety
    Llorca, P-M.
    Dumont, P.
    Palazzolo, J.
    Raymondet, P.
    Moreau-Mallet, V.
    Bouhours, P.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S270 - S270
  • [47] New for old? Risperidone long-acting injection in older patients
    Hudson-Jessop, Pamela
    Hughes, Brendan
    Brinkley, Neridah
    AUSTRALASIAN PSYCHIATRY, 2007, 15 (06) : 461 - 464
  • [48] Change in prepulse inhibition after switching schizophrenic patients from zuclopenthixol to long-acting injectable risperidone
    Rubio, G
    del Manzano, BA
    Ducaju, M
    Martínez-Gras, I
    Gimeno, D
    Borrel, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S475 - S475
  • [49] Proven maintained efficacy and safety in patients with paranoid schizophrenia after direct switch to risperidone long-acting injectable
    Parellada, E
    Kissling, W
    Bouhours, F
    Gallhofer, B
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S402 - S402
  • [50] COST OF LONG-ACTING RISPERIDONE INJECTION VERSUS LONG-ACTING PALIPERIDONE PALMITATE IN PATIENTS WITH SCHIZOPHRENIA IN RUSSIA
    Omelyanovsky, V
    Avxentyeva, M.
    Ivakhnenko, O.
    Khailov, P.
    Tsfasman, F. M.
    Krysanov, I
    Zorin, N.
    VALUE IN HEALTH, 2012, 15 (07) : A338 - A338
12345